Literature DB >> 12611843

Psychotic depression and mortality.

Meena Vythilingam1, Joyce Chen, J Douglas Bremner, Carolyn M Mazure, Paul K Maciejewski, J Craig Nelson.   

Abstract

OBJECTIVE: Major depressive disorder is associated with elevated mortality rates that increase with the severity of depression. The authors hypothesized that patients with psychotic depression would have higher mortality rates than patients with nonpsychotic depression.
METHOD: Survival analytic techniques were used to compare the vital status of 61 patients with psychotic major depression with that of 59 patients with nonpsychotic major depression up to 15 years after hospital admission. Medical status was assessed with the Cumulative Illness Rating Scale. Dexamethasone suppression test (DST) data were available for 101 patients.
RESULTS: The mortality rate for subjects with psychotic depression was significantly greater than that for those with nonpsychotic depression, with 41% versus 20%, respectively, dying within 15 years after hospital admission. A proportional hazards model with age and medical status entered as covariates confirmed a significantly higher mortality rate in patients with psychotic depression (hazards ratio=2.31). A positive DST result was associated with psychotic depression but was not related to vital status.
CONCLUSIONS: Patients with psychotic depression have a two-fold greater risk of death than do patients with severe, nonpsychotic major depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12611843     DOI: 10.1176/appi.ajp.160.3.574

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  30 in total

Review 1.  A review of postpartum psychosis.

Authors:  Dorothy Sit; Anthony J Rothschild; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2006-05       Impact factor: 2.681

2.  The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine.

Authors:  Pål Gjerden; Lars Slørdal; Jørgen G Bramness
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

3.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

4.  Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up.

Authors:  Pål Gjerden; Lars Slørdal; Jørgen G Bramness
Journal:  Eur J Clin Pharmacol       Date:  2010-06-03       Impact factor: 2.953

5.  Gray matter bases of psychotic features in adult bipolar disorder: A systematic review and voxel-based meta-analysis of neuroimaging studies.

Authors:  Xiuli Wang; Fangfang Tian; Song Wang; Bochao Cheng; Lihua Qiu; Manxi He; Hongming Wang; Mingjun Duan; Jing Dai; Zhiyun Jia
Journal:  Hum Brain Mapp       Date:  2018-08-10       Impact factor: 5.038

6.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 7.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

8.  Social support resources and post-acute recovery for older adults with major depression.

Authors:  Hong Li; Nancy Morrow-Howell; Enola Proctor; Eugene Rubin
Journal:  Community Ment Health J       Date:  2012-11-16

9.  Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic.

Authors:  Brandon A Gaudiano; Kristy L Dalrymple; Mark Zimmerman
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 10.  Challenges in the treatment of major depressive disorder with psychotic features.

Authors:  Anthony J Rothschild
Journal:  Schizophr Bull       Date:  2013-04-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.